These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7696024)

  • 1. Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
    Jakob G; Mair J; Pichler M; Puschendorf B
    Br Heart J; 1995 Feb; 73(2):145-50. PubMed ID: 7696024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure.
    Jakob G; Mair J; Vorderwinkler KP; Judmaier G; König P; Zwierzina H; Pichler M; Puschendorf B
    Clin Chem; 1994 Jan; 40(1):96-100. PubMed ID: 8287551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise.
    Szekeres T; Artner-Dworzak E; Puschendorf B; Fritzer M; Havel M; Gassner A; Fridrich L
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):69-74. PubMed ID: 8385504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Habitual activities and peak aerobic capacity in patients with asymptomatic and symptomatic left ventricular dysfunction.
    Mezzani A; Corrà U; Baroffio C; Bosimini E; Giannuzzi P
    Chest; 2000 May; 117(5):1291-9. PubMed ID: 10807813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
    Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
    Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin in human congestive heart failure.
    Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
    Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases.
    Vorderwinkler KP; Artner-Dworzak E; Jakob G; Mair J; Diensti F; Pichler M; Puschendorf B
    Clin Chem; 1991 Feb; 37(2):186-90. PubMed ID: 1847093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function.
    Trappe HJ; Wenzlaff P; Pfitzner P; Fieguth HG
    Heart; 1997 Sep; 78(3):243-9. PubMed ID: 9391285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary exercise response in patients with left ventricular dysfunction or heart failure: a noninvasive study by gas exchange and impedance cardiography monitoring.
    Romano M; Monteforte I; Cardei S; Lerro A; Celano G; Mazza A; Capaldo M; Paglia N; Campopiano A; Lembo G; Trimarco B; Condorelli M
    Cardiology; 1996; 87(2):147-52. PubMed ID: 8653732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
    Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
    Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.
    Williams SG; Ng LL; O'Brien RJ; Taylor S; Wright DJ; Li YF; Tan LB
    Int J Cardiol; 2005 Jul; 102(2):279-86. PubMed ID: 15982497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic and prognostic considerations in circulatory insufficiency in congestive heart failure: receptor function.
    Ogawa K; Ito T
    Jpn Circ J; 1989 Feb; 53(2):123-30. PubMed ID: 2541267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.